TY - JOUR
T1 - Participatory design of a personalized genetic risk tool to promote behavioral health
AU - Ramsey, Alex T.
AU - Bray, Michael
AU - Laker, Penina Acayo
AU - Bourdon, Jessica L.
AU - Dorsey, Amelia
AU - Zalik, Maia
AU - Pietka, Amanda
AU - Salyer, Patricia
AU - Waters, Erika A.
AU - Chen, Li Shiun
AU - Bierut, Laura J.
N1 - Funding Information:
A.T. Ramsey was supported by the National Institute on Drug Abuse (NIDA) grant K12DA041449. J.L. Bourdon was supported by NIDA grant T32DA015035. L-S. Chen was supported by the NCI grant P30CA091842-16S2 and NIDA grant R01DA038076. L.J. Bierut was supported by NIDA grant R01DA036583, National Center for Advancing Translational Sciences grant UL1TR002345, and NCI grant P30CA091842.
Publisher Copyright:
© 2020 American Association for Cancer Research.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Despite major advancements in genomic medicine, research to optimize the design and communication of genetically informed interventions in behavioral health has lagged. The goal of this study was to engage potential end users in participatory codesign of a personalized genetically informed risk tool to intervene on high-risk health behaviors. We used structured interviews to examine end-user attitudes and interest in personalized genetics, qualitative interviews to guide iterative design of a genetically informed tool, and questionnaires to assess acceptability and potential utility of the tool. Participants expressed strong demand for using personal genetics to inform smoking and alcohol-related disease risk and guide treatment (78%–95% agreed). Via iterative design feedback, we cocreated a genetically informed risk profile featuring (i) explanation of genetic and phenotypic markers used to construct a risk algorithm, (ii) personalized risks and benefits of healthy behavior change, and (iii) recommended actions with referral to freely available resources. Participants demonstrated sufficient understanding and cited motivating behavior change as the most useful purpose of the tool. In three phases, we confirmed strong desire for personalized genetics on high-risk health behaviors; codesigned a genetically informed profile with potential end users; and found high acceptability, comprehensibility, and perceived usefulness of the profile. As scientific discovery of genomic medicine advances in behavioral health, we must develop the tools to communicate these discoveries to consumers who stand to benefit. The potential of genomic medicine to engage populations and personalize behavioral health treatment depends, in part, on preparatory studies to design for the future implementation of genetically informed interventions.
AB - Despite major advancements in genomic medicine, research to optimize the design and communication of genetically informed interventions in behavioral health has lagged. The goal of this study was to engage potential end users in participatory codesign of a personalized genetically informed risk tool to intervene on high-risk health behaviors. We used structured interviews to examine end-user attitudes and interest in personalized genetics, qualitative interviews to guide iterative design of a genetically informed tool, and questionnaires to assess acceptability and potential utility of the tool. Participants expressed strong demand for using personal genetics to inform smoking and alcohol-related disease risk and guide treatment (78%–95% agreed). Via iterative design feedback, we cocreated a genetically informed risk profile featuring (i) explanation of genetic and phenotypic markers used to construct a risk algorithm, (ii) personalized risks and benefits of healthy behavior change, and (iii) recommended actions with referral to freely available resources. Participants demonstrated sufficient understanding and cited motivating behavior change as the most useful purpose of the tool. In three phases, we confirmed strong desire for personalized genetics on high-risk health behaviors; codesigned a genetically informed profile with potential end users; and found high acceptability, comprehensibility, and perceived usefulness of the profile. As scientific discovery of genomic medicine advances in behavioral health, we must develop the tools to communicate these discoveries to consumers who stand to benefit. The potential of genomic medicine to engage populations and personalize behavioral health treatment depends, in part, on preparatory studies to design for the future implementation of genetically informed interventions.
UR - http://www.scopus.com/inward/record.url?scp=85087530907&partnerID=8YFLogxK
U2 - 10.1158/1940-6207.CAPR-20-0029
DO - 10.1158/1940-6207.CAPR-20-0029
M3 - Article
C2 - 32209550
AN - SCOPUS:85087530907
VL - 13
SP - 583
EP - 591
JO - Cancer Prevention Research
JF - Cancer Prevention Research
SN - 1940-6207
IS - 7
ER -